Lincoln National Corp’s ResMed RMD Stock Holding History

Lincoln National Corp’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,692	Closed	-$731K	–	899
2024 Q1	$731K	Buy	3,692 +97	+3%	+$17.8K	0.01%	614
2023 Q4	$618K	Buy	+3,595	New	+$552K	0.01%	599

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Lincoln National Corp's RMD Position: Q2 2024 in Review

Lincoln National Corp sold out of ResMed (RMD) in Q2 2024, closing a stake of 3,692 shares — an estimated $731K sold.

Lincoln National Corp first reported a position in RMD in Q4 2023 and held it in 2 quarters. The position peaked at $731K in Q1 2024. 771 funds tracked by Wall St. Rank hold RMD as of Q2 2024.

Lincoln National Corp reported no remaining ResMed position as of Q2 2024 after selling out during the quarter.
Lincoln National Corp sold 3,692 ResMed shares in Q2 2024, an estimated $731K.
Lincoln National Corp first reported a position in ResMed in Q4 2023 and held it in 2 quarters.
Lincoln National Corp's ResMed position peaked at $731K in Q1 2024.
771 funds tracked by Wall St. Rank held ResMed as of Q2 2024.

Based on Lincoln National Corp's 13F filing for Q2 2024, filed 25 Jul 2024.